ARCHIVES

Amgen Announces Cochrane Findings: ESAs Increase Risk Of On-Study Death.

This article is from The Cancer Letter archive.

Vol. 34 No. 36 | October 3, 2008

Download PDF Visit The Full Archive

Related Articles

Costs of Rosenberg Regimen Could Hinder cooperative Group Trials

January 3, 1986

AIDs Concepts Totaling $13 Million Approved By DCT Board; Will Be Funded By Special Appropriations

October 11, 1985

In Brief: Pass Joins Karmanos Cancer Institute; Nag President-Elect, Brachytherapy Society

June 27, 1997

Philadelphia Group Begins BMT Trial for Breast Cancer

April 5, 1991

Mayo Clinic’s NCI Designation Extended To Arizona, Florida Sites

July 26, 2002

In Brief: Earl Pollack To Retire As Head Of Seer Program; Nursing Foundation, Lederle Offer Scholarships

December 7, 1984